OPS-2071

· Otsuka Beijing Research Institute

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for OPS-2071, covering 2014-11-07 to 2025-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Clinical Trial of OPS-2071 in the Treatment of Irritable Bowel Syndrome of Diarrhea Type [Phase 2]